The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 13, 2011

Filed:

Apr. 17, 2007
Applicants:

Hiroyuki Abe, Takatsuki, JP;

Masahiro Tanaka, Takatsuki, JP;

Kazuyuki Sugimoto, Takatsuki, JP;

Akira Suma, Takatsuki, JP;

Masahiro Yokota, Takatsuki, JP;

Makoto Shiozaki, Takatsuki, JP;

Kiyosei Iio, Takatsuki, JP;

Kazuhito Ueyama, Takatsuki, JP;

Dai Motoda, Takatsuki, JP;

Toru Noguchi, Takatsuki, JP;

Tsuyoshi Adachi, Yokohama, JP;

Junichiro Tsuruha, Yokohama, JP;

Satoki Doi, Yokohama, JP;

Inventors:

Hiroyuki Abe, Takatsuki, JP;

Masahiro Tanaka, Takatsuki, JP;

Kazuyuki Sugimoto, Takatsuki, JP;

Akira Suma, Takatsuki, JP;

Masahiro Yokota, Takatsuki, JP;

Makoto Shiozaki, Takatsuki, JP;

Kiyosei Iio, Takatsuki, JP;

Kazuhito Ueyama, Takatsuki, JP;

Dai Motoda, Takatsuki, JP;

Toru Noguchi, Takatsuki, JP;

Tsuyoshi Adachi, Yokohama, JP;

Junichiro Tsuruha, Yokohama, JP;

Satoki Doi, Yokohama, JP;

Assignee:

Japan Tobacco Inc., Tokyo, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/497 (2006.01); C07D 403/06 (2006.01); C07D 401/06 (2006.01); C07D 241/04 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to a compound represented by the following formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof, or a solvate thereof and an anti-HCV agent and an HCV polymerase inhibitor containing this compound. The compound of the present invention shows an anti-HCV activity based on the HCV polymerase inhibitory activity, and useful as an agent for the prophylaxis or treatment of hepatitis C.


Find Patent Forward Citations

Loading…